Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: Dose-response studies

Autor: Pritchett, Edward L.C., DaTorre, Steven D., Platt, Marc L., McCarville, Sally E., Hougham, Andrina J.
Zdroj: Journal of the American College of Cardiology; February 1991, Vol. 17 Issue: 2 p297-303, 7p
Abstrakt: The dose-response relations for efficacy and tolerance of the antiarrhythmic drug flecainide acetate were studied in 28 patients with paroxysmal supraventricular tachycardia (Group 1) and 45 patients with paroxysmal atrial fibrillation or flutter (Group 2). Recurrent symptomatic tachycardia was documented with use of transtelephonic electrocardiographic recording. Patients received flecainide in doses of 25, 50, 100 and 150 mg twice daily and placebo for 1 month treatment periods.
Databáze: Supplemental Index